08048036315
Premium Exporter of Genuine ENFIERA 500 Injection from India to Singapore – Orchard | Phoenix Exim

1. General Information

ENFIERA 500 Injection is a rituximab-based monoclonal antibody medicine. It works primarily by targeting CD20-positive B cells, which are involved in certain blood cancers and autoimmune diseases. It is used only when prescribed and is administered by a qualified healthcare professional.

Manufacturer/brand information: Current Indian listings identify ENFIERA with Zydus Lifesciences, while some listings also show Biochem Pharmaceutical Industries as the marketer/manufacturer. Therefore, the manufacturer should be verified from the specific vial and packaging being supplied.

2. Product Information

  • Brand: ENFIERA 500 Injection
  • Active ingredient: Rituximab
  • Strength: 500 mg/50 mL
  • Dosage form: Injection/infusion concentrate
  • Therapeutic class: Monoclonal antibody / antineoplastic and immunomodulatory medicine
  • Route: Usually administered by intravenous infusion by a healthcare professional
  • Storage: Refrigerated at 2–8°C; do not freeze
  • Prescription: Prescription-only medicine

3. Uses of ENFIERA 500 Injection

Depending on the patient's condition and physician's treatment plan, rituximab may be used for:

  • Non-Hodgkin lymphoma (NHL)
  • Chronic lymphocytic leukemia (CLL)
  • Rheumatoid arthritis
  • Granulomatosis with polyangiitis (GPA)
  • Microscopic polyangiitis (MPA)
  • Certain cases of pemphigus vulgaris

4. Benefits of This Medicine

The potential benefits depend on the condition being treated. By reducing targeted B-cell activity, rituximab can:

  • Help control certain B-cell blood cancers
  • Reduce abnormal immune-system activity in selected autoimmune diseases
  • Help reduce inflammation associated with conditions such as rheumatoid arthritis and vasculitis
  • Help control disease activity and prevent further complications in appropriately selected patients

It should not be described as a general-purpose cancer treatment; its use depends on the specific diagnosis and treatment protocol.

5. Side Effects of ENFIERA 500 Injection

Rituximab can cause infusion-related and immune-system-related adverse effects. Possible side effects include:

  • Infusion reactions
  • Fever and chills
  • Headache
  • Weakness
  • Nausea
  • Abdominal or back pain
  • Rash or itching
  • Infections
  • Reduced white blood-cell counts
  • Low lymphocyte counts

Some potentially serious complications include severe infusion reactions, serious infections, hepatitis B reactivation, cardiac problems and other rare complications. Patients should remain under appropriate medical monitoring during treatment.

6. Common Side Effects

Commonly reported effects include:

  • Headache
  • Weakness
  • Chills
  • Fever
  • Infection
  • Infusion-site/reaction symptoms
  • Neutropenia
  • Lymphopenia
  • Abdominal pain
  • Back pain

If symptoms are severe, persistent, or unusual, the treating doctor should be contacted promptly.

7. How to Use

ENFIERA 500 Injection must not be self-administered. It is administered by a doctor or trained healthcare professional, generally as an intravenous infusion.

The dose, infusion rate, treatment interval and number of doses vary according to the disease, treatment regimen and patient's condition. Patients should follow the exact protocol prescribed by their specialist.

The product should also be maintained under the recommended 2–8°C refrigerated storage conditions and should not be frozen.

8. How ENFIERA 500 Works

ENFIERA contains rituximab, a monoclonal antibody that targets the CD20 protein on B cells. By binding to these cells, rituximab helps the immune system eliminate targeted B cells. This can reduce abnormal B-cell activity in certain cancers and autoimmune disorders.

9. Safety Advice

  • Use only under the supervision of a qualified healthcare professional.
  • Tell your doctor about any active or recent infections before treatment.
  • Your doctor may need to check for hepatitis B before and during treatment because reactivation can occur.
  • Inform your doctor about previous heart problems, liver problems and other significant medical conditions.
  • Tell your doctor about all medicines, supplements and vaccines you are taking.
  • Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
  • Seek immediate medical attention for severe breathing difficulty, facial/throat swelling, severe rash, chest symptoms, high fever or other serious reactions.
  • Do not change the dose or treatment schedule yourself.

10. Frequently Asked Questions (FAQs)

Q1. What is ENFIERA 500 Injection?
ENFIERA 500 Injection is a rituximab 500 mg/50 mL monoclonal antibody medicine used for certain blood cancers and autoimmune disorders.

Q2. What is ENFIERA 500 Injection used for?
It may be prescribed for non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis and microscopic polyangiitis, with some additional approved/clinical uses depending on the treatment setting.

Q3. Can I administer ENFIERA 500 Injection myself?
No. It should be administered by a qualified healthcare professional under appropriate medical supervision.

Q4. How should ENFIERA 500 Injection be stored?
It should generally be stored under refrigeration at 2–8°C and must not be frozen.

Q5. Does ENFIERA 500 Injection cause infections?
Rituximab can increase susceptibility to infections because it affects B cells and the immune response. Patients should report signs of infection to their healthcare provider.

Q6. Does ENFIERA 500 Injection require a prescription?
Yes. It is a prescription medicine and should be used only according to a specialist's recommendation.

Q7. What should I tell my doctor before treatment?
Tell your doctor about infections, hepatitis B history, heart or liver problems, pregnancy/breastfeeding, allergies and all medicines you are taking.

11. Substitutes for ENFIERA 500 Injection

Possible rituximab 500 mg alternatives listed by Indian medicine sources include:

  • Reditux 500 mg Injection
  • Lupiximab 500 mg Injection
  • Ritucad 500 Injection
  • Other rituximab 500 mg products may also be available.

Important: A substitute should not be selected solely on the basis of price or brand name. The treating physician/pharmacist should confirm the appropriate rituximab product, strength, formulation and treatment regimen.

12. SEO / B2B Keywords

  • ENFIERA 500 Injection exporter from India
  • ENFIERA 500 mg Injection supplier India
  • ENFIERA 500 Injection pharmaceutical exporter
  • ENFIERA 500 mg rituximab injection supplier
  • Rituximab 500 mg Injection exporter India
  • Rituximab 500 mg/50 mL injection supplier
  • ENFIERA 500 Injection wholesale supplier
  • ENFIERA 500 Injection international supplier
  • ENFIERA 500 Injection for cancer treatment
  • Rituximab injection exporter from Nagpur India
  • ENFIERA 500 Injection supplier to USA
  • ENFIERA 500 Injection supplier to UK
  • ENFIERA 500 Injection supplier to Australia
  • ENFIERA 500 Injection supplier to Singapore
  • ENFIERA 500 Injection supplier to Canada
  • ENFIERA 500 Injection supplier to South Korea
  • ENFIERA 500 Injection supplier to UAE
  • Rituximab 500 mg pharmaceutical supplier
  • Rituximab monoclonal antibody injection exporter
  • ENFIERA 500 mg oncology medicine supplier
  • ENFIERA 500 Injection for non-Hodgkin lymphoma
  • ENFIERA 500 Injection for chronic lymphocytic leukemia
  • Rituximab injection for rheumatoid arthritis
  • Rituximab injection for granulomatosis with polyangiitis
  • ENFIERA 500 mg B-cell targeted therapy
  • Genuine ENFIERA 500 Injection supplier India
  • Cold-chain pharmaceutical exporter India
  • Prescription oncology medicine exporter India
  • Phoenix Exim ENFIERA 500 Injection exporter
Aug 20th, 2026 3:25 PM

Keywords